Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 68001-444

13 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 68001-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Cyclophosphamide Structural Formula (Image 01)
Chemical structure of cyclophosphamide, showing the molecular arrangement including a phosphorus atom bonded to oxygen, nitrogen with chlorinated ethyl groups, and a cyclic ether ring.*
FDA Label Image

Cyclo 500mg Vial Label (2020 500mg Vial)

Cyclo 500mg Vial Label (2020 500mg Vial)
Cyclophosphamide for Injection, USP 500 mg/vial injection powder label by BluePoint Laboratories. The label indicates it is a hazardous drug for intravenous use, single-dose vial, sterile and non-pyrogenic. Instructions include adding 25 mL of sterile water or 0.9% sodium chloride injection depending on administration method. Manufactured by Baxter Healthcare Corporation, product of Germany. Storage recommended at or below 25°C (77°F).*
FDA Label Image

Cyclophosphamide Label 500mg-vial 12-2024 (Cyclophosphamide Label 500mg Vial 12 2024)

Cyclophosphamide Label 500mg-vial 12-2024 (Cyclophosphamide Label 500mg Vial 12 2024)
Label for Cyclophosphamide for Injection, USP 500 mg/vial by BluePoint Laboratories. It is a hazardous drug for intravenous use, supplied as a sterile, non-pyrogenic, single-dose vial. The label includes instructions for IV infusion and direct injection preparation, storage temperature guidelines, manufacturer details, and a barcode.*
FDA Label Image

500mg Carton (2020 500mg Carton)

500mg Carton (2020 500mg Carton)
Packaging label for Cyclophosphamide for Injection, USP 500 mg/vial, a hazardous drug for intravenous infusion or direct injection. The label indicates it must be diluted and unused portions discarded. Manufactured by Baxter Healthcare Corporation for BluePoint Laboratories, this product is a single-dose vial containing injection powder for solution. The label includes usage instructions, storage conditions, and barcodes.*
FDA Label Image

Cyclophosphamide Carton 500mg-vial 12-2024 (Cyclophosphamide Carton 500mg Vial 12 2024)

Cyclophosphamide Carton 500mg-vial 12-2024 (Cyclophosphamide Carton 500mg Vial 12 2024)
Cyclophosphamide for Injection, USP 500 mg/vial powder for solution injection label. The label includes the drug name, strength, and hazardous drug warnings. It states that the vial is single-dose, sterile, non-pyrogenic, and intended for intravenous infusion or direct injection use after dilution. Manufacturer is Baxter Healthcare Corporation, made in Germany for BluePoint Laboratories. The label includes NDC 68001-442-26 and storage instructions.*
FDA Label Image

1gm Vial Label (2020 1g Vial)

1gm Vial Label (2020 1g Vial)
Label for Cyclophosphamide for Injection, USP 1 g/vial from BluePoint Laboratories. This single-dose sterile, non-pyrogenic vial is for intravenous use and labeled as a hazardous drug. Instructions include adding 50 mL of Sterile Water or 0.9% Sodium Chloride for injection. Manufactured by Baxter Healthcare Corporation, product of Germany.*
FDA Label Image

Cyclophosphamide Label 1g-vial 12-2024 (Cyclophosphamide Label 1g Vial 12 2024)

Cyclophosphamide Label 1g-vial 12-2024 (Cyclophosphamide Label 1g Vial 12 2024)
Label for Cyclophosphamide for Injection, USP 1 g/vial, a hazardous drug for intravenous use in a single-dose vial. The label includes instructions for reconstitution with sterile water or sodium chloride for injection, storage conditions, and manufacturer details. Made in Germany for BluePoint Laboratories.*
FDA Label Image

1gm Carton (2020 1g Carton)

1gm Carton (2020 1g Carton)
Packaging label for Cyclophosphamide for Injection, USP 1 g/vial powder for solution, manufactured by BluePoint Laboratories. The label indicates it is a hazardous drug for intravenous infusion or direct injection, must be diluted, and unused portions discarded. It provides storage instructions and preparation guidelines for intravenous and direct injection use. The label includes barcodes and states it is a single-dose vial.*
FDA Label Image

Cyclophosphamide Carton 1g-vial 12-2024 (Cyclophosphamide Carton 1g Vial 12 2024)

Cyclophosphamide Carton 1g-vial 12-2024 (Cyclophosphamide Carton 1g Vial 12 2024)
Cyclophosphamide for Injection, USP 1 g/vial packaging label by BluePoint Laboratories. The label indicates the product is a hazardous drug for intravenous infusion or direct injection use, must be diluted, and unused portions should be discarded. Manufactured by Baxter Healthcare Corporation, made in Germany. Includes instructions for diluting with sterile water or saline. Single-dose vial with NDC 68001-443-27.*
FDA Label Image

2gm Vial Lable (2020 2g Vial)

2gm Vial Lable (2020 2g Vial)
Label for Cyclophosphamide injection, USP 2 g per vial by BluePoint Laboratories. The product is a hazardous drug for intravenous use, supplied as a single-dose sterile, non-pyrogenic powder for solution. Instructions for preparation include adding sterile water or sodium chloride injection for infusion or direct injection. Manufactured by Baxter Healthcare Corporation as a product of Germany.*
FDA Label Image

Cyclophosphamide Label 2g-vial 12-2024 (Cyclophosphamide Label 2g Vial 12 2024)

Cyclophosphamide Label 2g-vial 12-2024 (Cyclophosphamide Label 2g Vial 12 2024)
Label for Cyclophosphamide for Injection, USP 2 g/vial by BluePoint Laboratories. This is a hazardous drug for intravenous use in a sterile, non-pyrogenic single-dose vial. Instructions include dilution for IV infusion or direct injection. Manufactured by Baxter Healthcare, made in Germany.*
FDA Label Image

2gm Carton (2020 2g Carton)

2gm Carton (2020 2g Carton)
Packaging label for Cyclophosphamide for Injection, USP 2 g per vial by BluePoint Laboratories. The label indicates it is a hazardous drug for intravenous infusion or direct injection use, requiring dilution, and instructs to discard unused portions. The label includes manufacturer information, lot and expiration date fields, and usage instructions for intravenous infusion and direct injection.*
FDA Label Image

Cyclophosphamide Carton 2g-vial 12-2024 (Cyclophosphamide Carton 2g Vial 12 2024)

Cyclophosphamide Carton 2g-vial 12-2024 (Cyclophosphamide Carton 2g Vial 12 2024)
Cyclophosphamide for Injection, USP 2 g/vial powder for solution carton label. The label indicates it is a hazardous drug for intravenous infusion or direct injection, requiring dilution and disposal of unused portions. Manufactured by Baxter Healthcare Corporation for BluePoint Laboratories. The label includes preparation instructions for intravenous infusion and direct injection, storage conditions at or below 25°C, and contains two barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.